Based in Austria, Allcyte is a startup. Allcyte has been acquired.
Allcyte is a biotech spin-off from CeMM that performs functional drug testing on fresh primary human cancer tissue using a high-content imaging platform called Pharmacoscopy to support drug discovery and precision/precision-medicine research. The company was acquired by Exscientia in 2021.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.